Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2013 1
2014 3
2015 8
2016 10
2017 7
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Correction: Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction.
Aratani K, Komatsu S, Ichikawa D, Ohashi T, Miyamae M, Okajima W, Imamura T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E. Aratani K, et al. Among authors: miyamae m. Oncotarget. 2019 Oct 1;10(55):5726. doi: 10.18632/oncotarget.27229. eCollection 2019 Oct 1. Oncotarget. 2019. PMID: 31620248 Free PMC article.
Low plasma levels of miR-101 are associated with tumor progression in gastric cancer.
Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Okamoto K, Fujiwara H, Otsuji E. Imamura T, et al. Among authors: miyamae m. Oncotarget. 2017 Sep 13;8(63):106538-106550. doi: 10.18632/oncotarget.20860. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29290969 Free PMC article.
Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction.
Aratani K, Komatsu S, Ichikawa D, Ohashi T, Miyamae M, Okajima W, Imamura T, Kiuchi J, Nishibeppu K, Kosuga T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E. Aratani K, et al. Among authors: miyamae m. Oncotarget. 2017 Sep 20;8(48):84112-84122. doi: 10.18632/oncotarget.21109. eCollection 2017 Oct 13. Oncotarget. 2017. PMID: 29137409 Free PMC article.
Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W, Komatsu S, Ichikawa D, Miyamae M, Ohashi T, Imamura T, Kiuchi J, Nishibeppu K, Arita T, Konishi H, Shiozaki A, Morimura R, Ikoma H, Okamoto K, Otsuji E. Okajima W, et al. Among authors: miyamae m. World J Gastroenterol. 2017 Aug 21;23(31):5650-5668. doi: 10.3748/wjg.v23.i31.5650. World J Gastroenterol. 2017. PMID: 28883691 Free PMC article. Review.
Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.
Imamura T, Komatsu S, Ichikawa D, Miyamae M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Konishi H, Shiozaki A, Morimura R, Ikoma H, Ochiai T, Okamoto K, Taniguchi H, Otsuji E. Imamura T, et al. Among authors: miyamae m. Sci Rep. 2017 Jul 18;7(1):5708. doi: 10.1038/s41598-017-06137-8. Sci Rep. 2017. PMID: 28720759 Free PMC article.
30 results